PLUS1
0.545
0.0449 (8.98%)
0.0449 (8.98%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 81,649 |
|
|||||
| News | - | ||||||
| Day High | 0.55 | Low High |
|||||
| Day Low | 0.51 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aprea Therapeutics Inc | APRE | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0449 | 8.98% | 0.545 | 11:56:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.51 | 0.51 | 0.55 | 0.5211 | 0.5001 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 315 | 81,649 | US$ 0.5272056 | US$ 43,046 | - | 0.304 - 2.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:53:51 | 15 | US$ 0.5201 | USD |
Period:
Draw Mode:
Aprea Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 28.88M | 53.00M | 41.96M | US$ - | US$ - | -1.74 | -0.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 2.70% |
Aprea Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 31/1/2023 | 09:20 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 31/1/2023 | 08:47 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 31/1/2023 | 00:00 | GlobeNewswire Inc. | Aprea Therapeutics Appoints John Hamill as Chief Financial.. |
| 27/1/2023 | 00:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 20/1/2023 | 00:00 | GlobeNewswire Inc. | Aprea Therapeutics to Participate in 6th Annual DNA Damage.. |
| 12/1/2023 | 01:25 | AllPennyStocks.com | Biotech Bid Up Following First Patient Dosage |
| 12/1/2023 | 00:00 | GlobeNewswire Inc. | Aprea Therapeutics Announces Dosing of First Patient in.. |
| 10/1/2023 | 00:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 16/12/2022 | 09:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
| 18/11/2022 | 08:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 16/11/2022 | 09:09 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 10/11/2022 | 22:25 | TipRanks | H.C. Wainwright Reaffirms Their Buy Rating on Aprea.. |
Historical APRE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.49 | 0.55 | 0.4611 | 0.4941614 | 80,215 | 0.055 | 11.22% |
| 1 Month | 0.40 | 0.60 | 0.3931 | 0.5101777 | 311,766 | 0.145 | 36.25% |
| 3 Months | 0.60 | 0.64 | 0.304 | 0.4594898 | 233,698 | -0.055 | -9.17% |
| 6 Months | 0.95 | 1.16 | 0.304 | 0.6073297 | 172,004 | -0.405 | -42.63% |
| 1 Year | 2.18 | 2.21 | 0.304 | 1.03 | 396,528 | -1.64 | -75.0% |
| 3 Years | 39.27 | 41.115 | 0.304 | 5.59 | 828,488 | -38.73 | -98.61% |
| 5 Years | 15.46 | 53.11 | 0.304 | 5.99 | 757,896 | -14.92 | -96.47% |